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Abstract
The fatal transmissions of highly pathogenic avian influenza A viruses (IAV) of the H5N1 subtype to humans and high titer
replication in the respiratory tract indicate that these pathogens can overcome the bird-to-human species barrier. While
type I interferons (IFN-a/b) are well described to contribute to the species barrier of many zoonotic viruses, current data to
the role of these antiviral cytokines during human H5N1 IAV infections is limited and contradictory. We hypothesized an
important role for the IFN system in limiting productive infection of avian H5N1 strains in human cells. Hence, we examined
IFN-a/b gene activation by different avian and human H5N1 isolates, if the IFN-a/b response restricts H5N1 growth and
whether the different strains were equally capable to regulate the IFN-a/b system via their IFN-antagonistic NS1 proteins.
Two human H5N1 isolates and a seasonal H3N2 strain propagated efficiently in human respiratory cells and induced little
IFN-b, whereas three purely avian H5N1 strains were attenuated for replication and provoked higher IFN secretion.
Replication of avian viruses was significantly enhanced on interferon-deficient cells, and exogenous IFN potently limited the
growth of all strains in human cells. Moreover, IFN-a/b activation by all strains depended on retinoic acid-inducible gene I
excluding principal differences in receptor activation between the different viruses. Interestingly, all H5N1 NS1 proteins
suppressed IFN-a/b induction comparably well to the NS1 of seasonal IAV. Thus, our study shows that H5N1 strains are
heterogeneous in their capacity to activate human cells in an NS1-independent manner. Our findings also suggest that
H5N1 viruses need to acquire adaptive changes to circumvent strong IFN-a/b activation in human host cells. Since no single
amino acid polymorphism could be associated with a respective high- or low induction phenotype we propose that the
necessary adaptations to overcome the human IFN-a/b barrier involve mutations in multiple H5N1 gene .
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Introduction
Influenza A viruses (IAV) are the prototypic members of the
Orthomyxoviridae and cause seasonal epidemic outbreaks of respira-
tory disease in humans with significant morbidity and mortality
[1]. The epidemiology of human influenza is strongly influenced
by a large natural reservoir of IAV in avian species. The
segmented RNA genome of influenza viruses allows for reassort-
ment of segments between human and avian IAV strains, which
was elemental for the generation and introduction of pandemic
IAV strains into the human population in 1957 and 1968 [2–4]. In
contrast, direct transmission of avian IAV to humans in toto has
been rarely noticed until the emergence of certain Asian H5N1
strains at the end of the last century [5,6]. While this indicates the
existence of a robust species barrier for avian IAV, it is still not
completely understood which factors prevent efficient replication
of avian influenza viruses in human hosts.
For a long period it was believed that the different receptors
avian and human IAV recognize via the hemagglutinin (HA) to
infect their respective target cells were the main reason for
inefficient replication of avian IAV in humans. The HA of most
avian strains recognizes terminal sialic acids with an a2,3-linkage
expressed on the surface of avian cells, while human IAV prefer
a2,6-linked sialic acids present on human tracheal cells [7].
However, human H5N1 isolates only rarely express HA proteins
with adaptive changes facilitating binding of ‘‘human’’ receptor
determinants [8–10]. In addition, a2,3-linked sialic acids were
recently shown to be present especially in the lower human
respiratory tract [11–15] indicating other factors to limit avian
IAV replication in humans in addition to receptor specificity.
Mutations in the viral polymerase increasing enzymatic activity
and enabling replication at lower temperatures have then been
identified as important requirements for adaptation [16,17].
Remarkably, human H5N1 infections are rather rare in regard
to the widespread exposure of humans to H5N1 viruses endemic
in poultry [18]. On the other hand, high virus loads observed in
H5N1 patients indicate that H5N1 viruses have the capacity to
efficiently replicate in human hosts despite the presence of a
vigorous cytokine response [19–22].
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It is well established that seasonal influenza viruses activate the
innate type I IFN response via viral 59-triphosphorylated (59-PPP)-
RNAs, which are sensed by the cytoplasmic sensor RIG-I [23–25].
Subsequently, RIG-I signaling activates the expression of IFN-a/b
genes via upregulation of the transcription factors IRF-3/27, NF-
kB and ATF-2/c-jun [26] and secreted IFN-a/b stimulates the
expression of more than 100 latent genes, many of which encode
factors with potent antiviral activity [27]. Type I interferon (IFN-
a/b) induction, if not avoided or dealt with by the virus, leads to
the establishment of an antiviral state in infected and bystander
cells, which effectively suppresses virus replication [28]. Seasonal
human influenza viruses achieve efficient replication by suppress-
ing the activation of IFN-a/b genes via their NS1 protein, a
pleiotropic factor that is abundantly expressed in infected cells
[24,25,29–35]. Earlier studies of H5N1 infections of human lung
epithelial cells and macrophages were inconclusive in this respect
as they reported either weak [30] or strong induction [36–38] of
IFN-a/b genes. This raised questions about the specific sensitivity
of H5N1 strains to IFNs, whether H5N1 viruses trigger an
alternative IFN induction pathway in human cells, and whether
they possibly encode NS1 proteins with compromised functions.
The purpose of this study was to examine our hypothesis that
the innate type I IFN response restricts the replication of H5N1
viruses in the human host and thereby contributes to the avian to
human species barrier. Hence we compared a panel of available
human and avian H5N1 strains with a prototypic seasonal IAV.
Since the viral NS1 proteins are known as the main influenza viral
regulator of the IFN-a/b response, we also put a special emphasis
on the functionality and mode of action of H5N1 NS1 proteins in
human cells.
Our analysis showed that two highly pathogenic human H5N1
isolates replicated at least as efficient as a prototypic seasonal
H3N2 strain in different human epithelial cells and induced
comparably low IFN-b secretion. In contrast, three analyzed avian
H5N1 isolates activated a much more pronounced IFN-b
secretion and were attenuated for replication indicating profound
differences in their interaction with cellular innate defenses.
Growth analyses of the H5N1 strains in IFN-deficient- and in IFN-
a pre-conditioned cells demonstrated that the human type I IFN
system potently reduces H5N1 virus growth. Viral IFN upregula-
tion uniformly depended on the RIG-I sensor protein indicating
that H5N1 viruses do not trigger an alternative IFN induction
pathway. Reverse genetic analyses showed that all H5N1 NS1
proteins antagonize IFN induction similar as their counterpart of a
prototypic seasonal strain. Hence we conclude that the IFN system
contributes to the bird-to-human species barrier and suggest that
efficient replication of H5N1 viruses in human cells requires
adaptive changes to accommodate to the new host.
Materials and Methods
Cells and Viruses
Human A549 lung epithelial cells (ATCC CCL-185) and 293T
cells (ATCC CRL-11268) were grown in Dulbeccòs modified
eagle medium (D-MEM) supplemented with 10% heat-inactivated
fetal bovine serum (FBS), 2 mM L-glutamine and antibiotics.
Madin Darby canine kidney cells (MDCK) cells (ATCC CRL-
2936) were cultivated in minimum essential medium (MEM)
containing 10% FBS, glutamine and antibiotics and Vero cells
were grown in serum-free Opti-Pro medium (Invitrogen). Unpo-
larized human bronchial epithelial Calu-3 cells (ATCC HTB-55)
were grown in Eagle’s minimal essential medium as described, but
15% FBS were used [30]. Normal human bronchial epithelial
(NHBE) cells (Lonza, Walkersville, USA) were grown as recom-
mended by the manufacturer. Frozen stock cells were thawed,
passaged once, seeded in 24-well-plates and used when nearly
confluent. All cells were cultured in monolayers, maintained at
37uC and 5% CO2.
The two highly-pathogenic H5N1 influenza A virus strains A/
Hong Kong/156/1997 (clade 0; obtained from the National
Institute for Biological Standards and Control, Hertfordshire, UK)
and A/Thailand/1 (KAN-1)/2004 (clade 1; obtained from P.
Puthavathana, Bangkok, Thailand) were previously isolated from
infected patients and are referred to as human H5N1 isolates
throughout this report [39,40]. The H5N1 strains A/chicken/
Indonesia/R132/2004 (clade 2.1.1), A/duck/Vietnam/TG24-
O1/2005 (clade 1) and A/common buzzard/Berlin/1/2006
(clade 2.2) were obtained from Brunhilde Schweiger (German
National Reference Centre for Influenza at the Robert Koch-
Institut, Berlin). All experiments and handling of samples
containing H5N1 infectious particles were done in a biological
safety level 3 facility. Stocks of human H5N1 isolates were grown
in MDCK cells, while the avian isolates were propagated in 10 day
old embryonated chicken eggs. The influenza A/Panama/2007/
1999 virus (Pan/99) was grown in MDCK cells and used in its
recombinant form as a prototypic seasonal influenza virus (see
below).
Generation of Recombinant Viruses
A recombinant eight plasmid system for the Pan/99 strain and
respective constructs encoding the NS segments of H5N1 viruses
were generated with the pHW2000 vector according to published
procedures [41]. All plasmids were verified to contain the specific
inserts with the expected sequence. The delNS1 construct was
generated by reverse transcription from NS2-mRNA using an
oligo-dT primer and amplification using the primers 59-TAT
TCG TCT CAG GGA GCA AAA GCA GGG TG-’3 and 59-
ATA TCG TCT CTT ATT AGT AGA AAC AAG GGT GTT
TTT TAT TAA ATA AGC TGA AAT G-‘3 resulting in an insert
encoding only the NS2 open reading frame flanked by the non-
coding regions of the viral NS segment. Recombinant Pan/99 and
mutant viruses were rescued by passaging cell culture supernatants
of 293T cells transfected with the eight respective pHW2000-
derived plasmids on Vero cells. The recombinant Pan/99 WT
virus showed similar multi-cyclic growth and IFN-b induction on
A549 cells compared to the natural isolate (data not shown).
IFN-aA/D- treatment of Cultured Cells
A549 cells were treated with 500 IU/ml of human IFN-aA/D
[BglII] (PBL) 6 hrs before infection and viral growth media was
supplemented with the same IFN-a concentration. Infected
cultures received fresh media containing IFN-a at each time-point
of sample acquisition to maintain media volume and IFN-a
concentration.
Infections and Plaque Titrations
For infections, 80 to 90% confluent cell cultures were incubated
with diluted stock virus for 45 min at room temperature. Infected
cells were washed and incubated with D-MEM supplemented with
0.2% bovine albumin, 2 mM L-glutamine, 100 U/ml penicillin,
100 mg/ml streptomycin and 0.4 mg/ml (A549 cells) or 1.0 mg/ml
of trypsin (MDCK, Vero cells). Plaque titer determination was
done by infecting confluent layers of MDCK cells with serial
dilutions of virus, which were then overlaid with 1.25% Avicel
RC581 (FMC) in MEM supplemented with 0.2% BA, 0.05%
NaHCO3 and 0.01% DEAE dextran [42]. Plaques were visualized
by either immunostaining of cells for viral nucleoprotein at 24 hrs
p.i. (hpi) or by staining with crystal violet at 48 hpi. To stain for
IFN-b Induction by H5N1 Influenza A Virus
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the IAV nucleoprotein, cells were permeabilized with 0.2% Triton
X-100 and plaques were visualized on a Li-Cor Odyssey platform
using a viral NP-specific monoclonal antibody (AbD Serotec
Division of MorphoSys, clone AA5H) and a secondary anti-mouse
IgG antibody (Li-Cor).
IFN-b ELISA
Cell culture supernatant samples from infected cell cultures
were stored at 280uC, thawed at room temperature and IFN-b
concentrations were measured using a human IFN-b ELISA Kit
(Fujirebio Inc./Invitrogen) according to the manufacturer’s
instructions.
Immunoblotting Analysis
Cells were lysed in Tris-HCl, pH 7.5 containing 1% NP40,
0.1% SDS, 2 mM EDTA, 10% glycerol, 137 mM NaCl and
protease inhibitors. Protein content of lysates was estimated via
Bradford assay (BioRad) and equal amounts of protein were
separated by SDS gel electrophoresis and transferred to Pro-
tranTM nitrocellulose membranes (Schleicher & Schüll, Germany).
The following primary antibodies were used for antigen detection:
mouse a-NP (AbD Serotec, clone AA5H), rabbit a-actin (Acris,
NB600-532), rabbit a-RIG-I (Axxora, ALX-210-932) as well as the
fluorophore-labeled secondary antibodies IRDye 800CW goat a-
rabbit and IRDye 600 goat a-mouse (Li-Cor) or respective
horseradish peroxidase-conjugated antibodies (Dako). Band inten-
sities were quantified using the Li-Cor Odyssey software.
siRNA Transfection Experiments
RIG-I-specific small interfering (si)RNA and non-target control
siRNA used were previously described [25]. A549 cells seeded in
12-well plates were transfected with 150 ng siRNA and 6 ml
HiPerfect (Qiagen, Hilden) according to the manufacturer’s
protocol. 36 to 48 hrs after transfection, cells were infected with
virus and IFN-b concentrations and knock-down efficiencies were
determined by densitometric quantification of immunoblot blot
bands from RIG-I and tubulin loading controls.
IFN-b Promoter Luciferase Reporter Assay
293T cells were transfected in triplicates in poly-D-lysine coated
12-well plates using Lipofectamine2000 (Invitrogen). Cells were
co-transfected with 1 mg of empty vector or pHW2000-NS
plasmid, 50 ng of the IFN-b promoter reporter p125-luc and the
pRL-TK-luc plasmid (Promega) to normalize transfection effi-
ciency as described [25,43]. 30 hrs post transfection cells were
infected with Pan-delNS1 virus (MOI = 1) or mock infected.
Cellular luciferase activities were determined 16 hrs p.i. using the
Dual Luciferase Kit (Promega). The respective firefly luciferase
activities were normalized and the increase in reporter activity in
Pan-delNS1 infected cells compared to mock-infected cells was
calculated.
Statistical Analysis
Data is presented as mean +/2 SEM if not indicated otherwise.
The two-tailed student’s t-test was used to delineate significant
differences between data points using the Prism6 software (Graph
Pad), p#0.05 was considered significant. Significance is depicted
as * for p#0.05, ** for p#0.01 and *** for p#0.001, respectively.
Sequences
The hitherto unpublished sequences for A/Common buzzard/
Berlin/1/2006 (EPI349049-52, EPI346565, EPI346566, and
EPI346568) and A/Chicken/Indonesia/R132 (EPI354072–78
and EPI354080) were submitted to the GISAID database
(http://gisaid.org) and complete sequence information for A/
Panama/2007/99 (DQ487333-40) was deposited at Genbank
(http://www.ncbi.nlm.nih.gov). Sequence information of the
remaining H5N1 strains can be accessed in GISAID (A/Duck/
Vietnam/TG24/05, EPI_ISL_70397) and Genbank (A/Hong
Kong/156/97 and A/Thailand/1 (KAN-1)/2004).
Results
Replication of Human and Avian Influenza H5N1 Virus
Isolates in Human Lung Epithelial Cells
We compared five closely related influenza A virus isolates of
the H5N1 subtype with the prototypic seasonal H3N2 strain A/
Panama/2007/99 (Pan/99) for viral growth and activation of the
type I IFN system in human cells. The H5N1 strains A/Hong
Kong/156/97 (HK/97) and A/Thailand/1(Kan-1)/2004 (Thai/
04) were derived from lethally infected human patients, whereas
A/chicken/Indonesia/R132/2004 (Ch/Ind), A/duck/Vietnam/
TG24-O1/2005 (Duck/VN) and A/common buzzard/Berlin/1/
2006 (Buzz/Bln) were of avian origin. Since we analyzed the
contribution of the viral NS1 protein in the control of type I IFN
induction, we also included a delNS1 deletion variant of the Pan/
99 (H3N2) virus lacking the NS1 coding region in our study [44].
The two human H5N1 isolates reached approximately four
times higher titers during multi-cyclic growth on human A549
lung epithelial cells than the seasonal H3N2 strain at 48 hrs p.i.
(Figure 1A). In contrast, growth of the three avian H5N1 isolates
was considerably lower in the range of one (Duck/VN, Buzz/Bln)
to four (Ch/Ind) orders of magnitude, respectively. The Pan-
delNS1 virus did not replicate in these cells demonstrating the
essential contribution of NS1 to efficient viral growth, which is
consistent with previous findings for delNS1 derivatives of the
mouse-adapted strains A/PR/8/34 (H1N1) and A/SC35M
(H7N7) [29,45]. Replication of avian H5N1 viruses was also
attenuated in human bronchiolar Calu-3 cells and primary
bronchiolar epithelial cells by one or more logs compared to the
human H5N1 isolates, suggesting a generally compromised
capacity of the avian strains to replicate in human cells (Figure
S1A and B). Single-cycle growth analysis confirmed the compro-
mised growth of the avian H5N1 strains in human cells, since the
human H5N1 isolates also replicated considerably faster, with the
Thai/04 isolate reaching titers three orders of magnitude higher
than the avian H5N1 isolates at 15 hrs p.i. (Figure 1B). The poor
growth of the avian H5N1 isolates was most likely not caused by a
generally low rate of primary infection, since the amounts of viral
nucleoprotein (NP) detected in cells infected with avian strains
were comparable or even higher than in cells infected with human
isolates (Figure 1C).
Differential Induction of IFN-b of Human and Avian
Influenza H5N1 Virus Isolates
Analyzing the accumulation of type I IFN in the supernatants of
infected A549 cells, we noticed that the poorly growing avian
H5N1 strains induced an up to 15 times stronger IFN-b secretion
from human cells than the human H5N1 and seasonal viruses,
regardless whether infection was initiated at low (24 and 48 hpi) or
high (16 hpi) multiplicity (Figure 1D and E). Conversely, there
were only minor differences in the low IFN-b inductions between
the well growing human isolates (HK/97 and Thai/04) and the
seasonal Pan/99 strain. The Pan-delNS1 mutant virus strongly
induced IFN-b when applied at high MOI (Figure 1E), but failed
to do so after low multiplicity infection (Figure 1D), most likely due
to its inefficient replication (Figure 1A). Of note, we also evaluated
IFN-b Induction by H5N1 Influenza A Virus
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the human and avian virus strains for their capacity to stimulate
IFN-b secretion from primary monocyte-derived macrophages
and human bronchiolar Calu-3 cells, and noticed similar ratios of
IFN secretion as were observed for A549 cells infected at high
MOI (Figure S2 and data not shown). These findings indicated
that H5N1 influenza viruses vary in their capacity to inhibit and/
or to induce antiviral IFN-b in human cells and suggested that IFN
Figure 1. Replication and IFN-b induction by human and avian H5N1 strains in human cells. (A, B) A549 cells were infected at a
multiplicity of 0.01 (A) or 1 (B) with the highly-pathogenic human H5N1 IAV isolates A/Hong Kong/156/1997 (HK/97) and A/Thailand/1 (KAN-1)/2004
(Thai/04), the avian H5N1 strains A/chicken/Indonesia/R132/2004 (Ch/Ind), A/duck/Vietnam/TG24-O1/2005 (Duck/VN) and A/common buzzard/Berlin/
1/2006 (Buzz/Bln) as well as with the prototypic seasonal A/Panama/2007/99 (Pan/99) H3N2 virus and its mutant variant with a deleted NS1 gene
(Pan-delNS1; shown only in panel A). Supernatant of infected cell cultures was sampled at the indicated time points and viral titers were determined
by plaque assay. Mean data+SEM of at least three independent experiments is shown. (C) Immunoblot analysis of lysates from A549 cells infected at
MOI = 1 using a viral NP-specific antibody at the indicated time points post infection (p.i.). Relative intensities of NP bands normalized to actin
controls are depicted in comparison to Thai/04, which was arbitrarily set as 100%. (D, E) Concentrations of IFN-b in cell culture supernatants of A549
cells infected with the indicated viruses at low (MOI = 0,01, panel D) or high multiplicity (MOI = 1, panel E) determined via ELISA at 24 and 48 hpi (D)
or at 16 hpi (E). Mean data of at least three independent experiments +/– SEM is shown. Symbols indicate significant differences between given
results with p,0.05 (*), p,0.01 (**), or p,0.001(***), respectively, as determined by unpaired two-tailed t-tests.
doi:10.1371/journal.pone.0056659.g001
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hyper-induction can cause or contribute to the attenuated
propagation of the avian H5N1 isolates.
H5N1 Virus Growth is Sensitive to IFN-a/b
To examine if there was a causal relationship between strong
IFN-b secretion and low replication of some H5N1 strains, we
studied their replication in A549 cells pre-conditioned and treated
with 500 IU/ml IFN-a throughout the experiment. IFN treatment
strongly reduced the growth of all human and avian strains up to
five orders of magnitude compared to non-treated cells (Figure 2A).
The human Thai/04 (H5N1) strain still reached the highest titers
among the investigated strains. Thus, IFN-a/b potently restricted
H5N1 virus growth in human cells and its strong induction by the
avian H5N1 viruses is likely to compromise their growth on
human lung cells.
To further validate that the IFN system does restrict H5N1
growth, we also examined viral propagation on Vero cells that lack
functional IFN-a/b genes [46,47] and expected enhanced growth
especially of the strongly IFN inducing strains. In fact, the
replication of the Pan-delNS1 mutant virus in these IFN-deficient
cells was increased by six logs compared to A549 cells (compare
Figures 2B and 1A), highlighting the importance of NS1-mediated
suppression of the innate antiviral defense [48]. The human H5N1
strains and the Pan/99 WT virus reached similar titers in both cell
lines, indicating their capacity to replicate efficiently in an
interferon-competent host cell. Interestingly, in Vero cells the
replication of the avian strains was much more similar to that of
the human isolates. While in A549 cells at 48 hrs p.i. the titers for
avian strains Ch/Ind, Duck/VN and Buzzard/Bln were approx-
imately 52.000-, 81- and 69-fold lower than that of the human
HK/97 strain (Figure 1A), these differences were reduced to 25-,
2- and 2-fold in Vero cells, respectively (Figure 2B).
The IFN-a/b System is Activated via RIG-I during H5N1
Infection
An explanation for the higher levels to which the avian H5N1
isolates induced IFN-b secretion in human cells could be that they
stimulate IFN-a/b induction in a different manner than human
IAV, which are known to trigger IFN-a/b secretion via the RNA
helicase RIG-I and to suppress this pathway via their NS1 proteins
[25,49]. We hence considered three different explanations for the
more extensive induction of IFN-b by the avian H5N1 strains in
our analysis: First, activation of a cellular receptor governing an
alternative or additional IFN-a/b inducing pathway not blocked
by the viral NS1 protein. Second, an insufficient inhibition of
RIG-I signaling by the ‘‘avian’’ NS1 proteins, or third, a
hyperstimulation of RIG-I signaling during avian H5N1 infec-
tions.
To test whether H5N1 isolates might induce IFN-a/b via a
different pathway, we explored the consequences of siRNA-
mediated knock-down of RIG-I in A549 cells on IFN-a/b
induction during H5N1 virus infection. Immunoblot analysis of
siRNA-treated cells confirmed a reduction of RIG-I protein levels
by 85% on average (Figure 3, lower panel) as determined by
densitometric analysis. Expression of other RNA sensors like
MDA5, DDX1 and TLR3 was not affected by siRNA treatment
(data not shown). Significantly, cells transfected with the RIG-I-
specific siRNA secreted uniformly about 80% less IFN-b after
infection with each of the viruses compared to control siRNA
transfected cells (Figure 3) (p = 0.0411, exact p-value, two-tailed
Mann-Whitney test). The strong decrease in IFN-b accumulation
in supernatants of cells with little detectable RIG-I, suggests that
other, RIG-I-independent, signaling pathways do not contribute
significantly to the induction of IFN-a/b during avian H5N1 virus
infections in human cells.
The H5N1 NS Segments Complement the Growth of a
Seasonal H3N2 Virus in Human Cells and Encode
Functional IFN Antagonists
Next, we examined the capacity of the H5N1 NS1 proteins to
inhibit the RIG-I mediated induction of IFN-b in human cells. All
five NS1 proteins share less than 80% sequence identity on the
amino acid level with their counterpart of the seasonal Pan/99
virus. Among the H5N1 NS1 homologs, the HK/97 differed by
up to 13% from the four other strains, which in turn differed by
less than 6% from each other. Thus, we generated and
characterized 7+1 reassortant viruses that carry the respective
H5N1-NS gene segments in the background of the seasonal Pan/
99 strain (H3N2). Interestingly, the heterologous H5N1-NS
segments complemented the growth of the H3N2 reassortants in
human A549 cells to a similar level as was observed for the
parental Pan/99 virus. Only the Pan/996Ch/Ind-NS reassortant
was attenuated to some extent (Figure 4A), but still rescued the
replication of the reassortant by more than 4 orders of magnitutde
compared to the NS1-deleted Pan/99 mutant virus (Figure 1A).
Figure 2. H5N1 virus growth is sensitive to IFN-a/b. (A) A549 lung
epithelial cells were treated with 500 U/ml recombinant IFN-a before
and during infection with the indicated virus strains (MOI = 0.01). Viral
titers were determined by plaque assay. Mean titers at 24 and 48 hours
post infection of at least 3 independent experiments+SEM are
presented. For comparison, the graph also depicts virus titers
determined in untreated A549 cells at 24 and 48 hpi. shown in
Figure 1A. Symbols indicate significant differences between given
individual results with p,0.05 (*) or p,0.01 (**), respectively. (B) Virus
growth of human and avian H5N1 isolates, Pan/99 (H3N2) and its
deltaNS1 variant on IFN-a/b-deficient Vero cells infected at a MOI of
0.01. Samples of the infected cell cultures supernatants were taken at
the indicated time-points and viral titers were determined by plaque
assay (mean data+SEM; N $3).
doi:10.1371/journal.pone.0056659.g002
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Thus, the efficient growth of the reassortant viruses indicated that
the encoded H5N1-NS1 proteins function well in human cells.
We also examined the propagation of these reassortant viruses
in IFN-a-treated cells, since H5N1 NS1 proteins had previously
been reported to interfere with IFN signaling and enhance virus
replication [50]. However, the growth of all reassortants was
strongly attenuated by IFN treatment (Figure 4B) as had also been
observed for the parental viruses (Figure 2A).
Figure 3. IFN-a/b secretion in response to H5N1 infection depends on RIG-I expression. A549 cells, transfected with either RIG-I-specific (+,
open columns) or control (–, solid columns) siRNA were infected with the indicated H5N1 and the Pan/99 (H3N2) derived viruses (MOI = 1). IFN-b
concentrations were determined via ELISA (Fujirebio, Japan) in cell culture supernatants taken 16 h post infection (upper panel) and RIG-I expression
was determined by immunoblotting (lower panel). Mean data +/– SEM of four independent experiments and a representative immunoblot is shown.
doi:10.1371/journal.pone.0056659.g003
Figure 4. Replication of reassortant Pan/99 (H3N2)6H5N1-NS viruses in lung epithelial cells. (A) A549 cells were infected with the
indicated Pan/99 (H3N2) wild-type and reassortant viruses carrying a H5N1-NS segment (MOI = 0.01). Aliquots of the supernatants were taken at the
indicated time points and viral titers were determined by plaque titration. Mean data of at least two independent experiments+SEM are shown. (B)
Virus growth on IFN-a treated A549 cells (500 IU/ml, 6 h before infection (MOI = 0.01) and during virus growth) was determined as described in panel
A. Shown are the average results of two independent experiments+SEM.
doi:10.1371/journal.pone.0056659.g004
IFN-b Induction by H5N1 Influenza A Virus
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To further explore the IFN antagonistic activity of the different
H5N1 NS1 proteins, we quantified IFN-b release from human
cells infected with the reassortant viruses. This analysis showed
that the reassortants induced equally low (Pan/996HK/97-NS) or
even less IFN-b secretion compared to the Pan/99 WT virus
(Figure 5A), which was consistent with their efficient growth in
A549 cells (Figure 4A). Hence, the reduced growth of the Pan/
996Ch/Ind-NS reassortant virus (Figure 4A) resulted most likely
from a reduced compatibility between the Ch/Ind NS- and
residual Pan/99 proteins, but not from a stronger type I IFN
induction.
We also employed an established reporter assay to examine the
suppression of viral IFN-beta promoter activation by the H5N1
NS1 proteins [25]. 293T cells were co-transfected with an IFN-b
promoter reporter and NS1 expression plasmids or empty vector.
Subsequently, cells were infected with the Pan-delNS1 virus for
16 hrs before reporter activity was determined. The Pan-delNS1
virus increased IFN-b promoter activity by 8-fold, whereas the
reporter was hardly activated in cells expressing the respective
NS1 proteins regardless of whether they were derived from a
human or an avian virus strain (Figure 5B). Equal infection of the
transfected A549 cells by the Pan/99-delNS1 mutant virus was
verified by immunoblot detection of the viral NP (Figure 5C).
Collectively, these findings demonstrate that NS1 proteins
encoded by either human or avian H5N1 strains efficiently
antagonize the induction of the IFN-a/b system in human lung
cells.
Comparison of the H5N1 Influenza Virus Backgrounds
The results indicated so far that differential activation of the
IFN-a/b system by the panel of H5N1 viruses was neither
influenced by a RIG-I-independent signaling pathway nor by a
failure of some NS1 proteins to silence IFN-a/b gene expression.
Thus, other viral signatures appear to be responsible for the
observed strain-specific growth- and IFN induction phenotypes.
To discover a putative underlying genetic element(s) we sequenced
the examined H5N1 isolates and screened them for genetic
polymorphism(s) previously described to be involved in H5N1
adaptation to mammalian hosts and/or pathogenicity [51–56]. In
Table 1, these specific amino acid positions in the viral proteins
previously linked with viral pathogenesis and/or adaptation to
mammalian hosts are summarized for the different virus strains.
Unfortunately, none of those specific amino acid constellations
alone such as the PB2 polymorphisms E627K or D701N could
explain the differences observed between the avian and human
strains as these did not display common phenotype-specific
variations. In fact, the three analyzed avian H5N1 strains have
only two differences to the human strains in common: Ile-168 of
the M1 protein and Thr-127 of the NS1 protein (Table 2). Thr-
168 in the M1 protein of the human H5N1 isolates is unlikely to
reflect an adaptive change as 30% of avian and 50% of human
H5N1 isolates have a Thr residue at this position. Interestingly,
NS1 amino acid 127 of seasonal IAV has been described to
regulate the antiviral kinase PKR [57]. However, we did not
observe differences in the activation of PKR by human or avian
H5N1 strains (data not shown). Hence, the different phenotypes
observed are presumably caused by the interplay of strain-specific
polymorphisms and are possibly encoded in more than one single
viral gene.
In conclusion, our study revealed that the ability to prevent or
avoid induction of the human type I IFN system substantially
contributes to enhanced replication of H5N1 viruses. This finding
is corroborated by the inverse correlation of strong IFN-b
induction with reduced replication among the human and avian
H5N1 strains. Surprisingly, all H5N1 NS1 proteins functioned as
effective IFN antagonists in infected and transfected cells
indicating that not a limitation in avian NS1 activity but rather
Figure 5. H5N1 NS1 proteins inhibit the induction of type I IFN in human cells. (A) IFN-b concentrations of supernatants sampled from
A549 cell cultures infected with the Pan99 WT and different NS reassortant viruses (H3N2) (MOI = 0.01) at 24 and 48 hrs p.i., (N$2+/–SEM). (B) Human
293T cells were co-transfected with plasmids expressing the H5N1- or Pan/99 (H3N2)-derived NS segments or empty vector, the human IFN-b
promoter reporter plasmid p125-Luc and pRL-TK-Luc to control for transfection efficiency. Subsequently, cells were infected for 16 h with Pan-delNS1
to stimulate the IFN-b promoter before luciferase reporter activity was determined in cell lysates. IFN-b promoter activation in infected cells is shown
as x-fold stimulation of firefly luciferase activity compared to transfected and mock infected cells. Mean data of three independent experiments is
shown +/– SD. (C) Immunblot detection of viral NP after Pan-delNS1 (H3N2) infection confirmed equal stimulation of the transfected cells analyzed in
panel B.
doi:10.1371/journal.pone.0056659.g005
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an exceptionally strong IFN induction by the tested avian strains
restricts viral replication in human cells.
Discussion
Highly pathogenic H5N1 strains of the Asian lineage circulating
in birds since 2003 are unique as they cause few but regular
human infections and a case fatality of almost 60% [58], while
most other avian influenza viruses are not known to infect humans.
Given the recent indications for the occurrence of mild or even
asymptomatic H5N1 infections, it is unclear whether all or only a
fraction of the circulating H5N1 strains have this high virulence
potential in humans as even highly related virus isolates differ
considerably in their pathogenicity in mammalian species like mice
and ferrets [59–61]. Since human airways express both a2,6- and
a2,3- linked receptors [13] and therefore receptor specificity is
unlikely to completely explain the severe outcomes of H5N1
infections in humans, we examined a potential contribution of the
human type I IFN system to the bird-to-human species barrier.
Special emphasis was put on the activation and suppression of the
human type I IFN system by H5N1 viruses since many examples
have shown that innate immune responses restrict the replication
Table 1. Differences in H5N1 influenza virus proteins*.
Virus strain PA PB1 PB1-F2 PB2
127 336 317 66 271 318 355 627 701 702
A/Hong Kong/156/1997 V L I N T R K E D K
A/Thailand/1 (Kan-1)/2004 V L M N T R R E N K
A/chicken/Indonesia/R132/2006 V L M N T R R E D K
A/duck/VietNam/TG24-01/2005 V L M N T R R E D K
A/common buzzard/Berlin/1/2006 V L M N T R R K D K
A/Panama/2007/1999 V L M N A R R K D R
NS1 NS2
42 D80–84 92 103 106 189 195 228 31 56
A/Hong Kong/156/1997 S 2 E L I D S P M H
A/Thailand/1 (Kan-1)/2004 S + D F M D T S M H
A/chicken/Indonesia/R132/2006 S + D F M D S S M H
A/duck/VietNam/TG24-01/2005 S + D F M D T S M H
A/common buzzard/Berlin/1/2006 S + D F M D S S M H
A/Panama/2007/1999 S 2 D F M D S S M H
HA1 NA
86 124 138 156 212 228 263 DStalk
A/Hong Kong/156/1997 A N L A E G T +
A/Thailand/1 (Kan-1)/2004 V S Q T R G T +
A/chicken/Indonesia/R132/2006 A D L A K G A +
A/duck/VietNam/TG24-01/2005 V S Q T R G T +
A/common buzzard/Berlin/1/2006 A D Q A K G T +
A/Panama/2007/1999 A 2 R K N S S 2
*Shown are amino acids at positions associated with high pathogenicity or replication competence of H5N1 viruses in mammals. Amino acids described to confer high
pathogenicity/virulence are shown in bold [51–57,79–82]; summarized in: [101]. No relevant positions were noticed in NP, and parts of the human H5N1 isolates’ PB2
and NP sequences were taken from public databases.
doi:10.1371/journal.pone.0056659.t001
Table 2. Common differences between examined human
and avian H5N1 strains*.
NS1 M
Virus strain 127 168
A/Hong Kong/156/1997 D T
A/Thailand/1 (Kan-1)/2004 V T
A/chicken/Indonesia/R132/2006 T I
A/duck/Vietnam/TG24-01/2005 T I
A/common buzzard/Berlin/1/2006 T I
A/Panama/2007/1999 N T
*Shown are the only two amino acid positions in which the examined avian
H5N1 isolates commonly differ to the human H5N1 strains.
doi:10.1371/journal.pone.0056659.t002
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of RNA viruses in a new host [62–66] and we wondered whether
this is also the case for avian and/or human H5N1 isolates.
We observed, that the growth of different H5N1 isolates from
birds or humans was significantly reduced on IFN-a pretreated
cells which is in line with and extends previous reports showing
that type I IFNs have a clear antiviral effect against H5N1 viruses
in several mammalian species [18,30,50,67–70]. Interestingly, at
least two of three avian isolates examined induced an enhanced
secretion of IFN-b from human epithelial cells and showed an
attenuated growth, while a seasonal H3N2 strain and the two
human H5N1 isolates induced only little IFN secretion and
replicated efficiently (Figure 1). Although it is tempting to
speculate that low IFN induction is a distinctive feature of
H5N1 patient isolates, we are aware that additional analyses are
required to validate this conclusion. Replication of the avian
isolates but not the human strains was strongly increased on IFN
deficient primate Vero cells (Figure 2B), which is in line with a role
of the type I IFN system to limit their growth in IFN-competent
cells. Hence, our study revealed a significant contribution of the
type I IFN system to limit H5N1 replication in human cells.
Enhanced IFN-a/b responses in human cells have also been
reported for avian H4, H7 and H12 subtype viruses [71,72] and
may indicate a common feature of avian IAV in human cells.
Interestingly, the human H5N1 isolates and the seasonal H3N2
strain showed similarly efficient growth and provoked only a
modest type I IFN response in human lung cells and macrophages,
which agrees with an earlier report [30], but seemingly differs from
others [36,37]. However, these apparent differences in the
outcomes might be explained retrospectively by strain specific
differences in regard to the H5N1 strains analyzed and the
respective H1N1 and H3N2 seasonal control strains [73,74].
The heterogeneous phenotypes of the examined human and
avian H5N1 viruses concerning growth and IFN control in human
cells, prompted us to examine possible mechanistic explanations
for this phenomenon. We and others have previously established
that seasonal IAV infections are recognized via RIG-I that is
regulated by the viral NS1 protein [25,30,32,49]. However, it had
not been excluded that H5N1 viruses stimulate an additional or
alternative IFN inducing signaling pathway such as the ones
governed by the cellular MDA5, DDX1, TLR3 or TLR8/9
receptors [75,76]. Still, our analysis showed that human RIG-I
functions also as the major sensor for avian H5N1 viruses since its
knock-down almost eliminated IFN-b production in infected
epithelial cells (Figure 3). This confirms and extents a similar
recent finding for H5N1 virus of the outbreak in Hong Kong in
1997 [77]. Interestingly, the phenotypes of Pan/99-derived 7+1
reassortant viruses expressing heterologous NS segments indicated
that the NS1 proteins of both avian und human H5N1 isolates
promoted virus replication (Figure 4) and suppressed activation of
the human IFN-b promoter (Figure 5) in human cells. The latter
aspect is reminiscent to a study of divergent NS1 proteins from
unrelated avian viruses which also effectively antagonized the
human type I IFN system [71]. Hence, we have to reject the
possibility that differences in the NS1 proteins explain why some
H5N1 strains replicated well in the human host, while others did
not. This is in contrast to the findings of a recent study showing
that mutations in the NS1 protein of a H3N2 subtype virus
contribute to enhanced IFN antagonism and replication in
mammalian cells [78]. Rather than NS1, our results suggest the
involvement of other viral factors, in which allelic differences
generated before or during virus transmission from an avian to a
human host contribute to the low IFN inducing potential of the
examined human H5N1 strains, in contrast to the avian isolates.
Previous comparisons of closely related H5N1 isolates with high
and low pathogenicity identified a number of amino acid
polymorphisms in the HA, polymerase and NS genes that increase
viral virulence and/or replication in mammalian hosts (Table 1)
[51,54,78–82]. To explain the abundant IFN induction by some
H5N1 strains despite expression of functional NS1 proteins, we
consider two possibilities: First, the viral polymerase synthesizes
full-length genomic viral 5̀-PPP RNAs and shorter versions thereof
that stimulate RIG-I in infected cells [24,83,84]. Thus, we
speculate that strong viral IFN-b induction could be caused by
an excess production of 59-PPP-RNAs that overwhelms the
inhibition by viral antagonistic proteins in infected human cells.
Accordingly, increased polymerase activity and IFN-b induction
correlated in a study with chimeric viruses expressing the PA
subunit of an H5N1 virus [85]. Our amino acid alignments failed
to associate a single genetic determinant in the viral polymerase
genes with this phenotype. However, identification of the
responsible element(s) is likely to be a complex task, since the
activity of influenza virus polymerase in mammalian cells is not
only controlled by polymorphic amino acids such as the ones
found at positions 701 or 627 in PB2 [19,86–88]. Rather, the levels
of viral 59-PPP-RNAs synthesized in infected cells are also
regulated by the viral NEP [89,90] indicating that the kinetic,
stability and level of NEP expression are important elements of
polymerase regulation, which are poorly defined yet. Second,
control of RIG-I-dependent signals by IAV is more complex than
was previously appreciated. Recent analyses showed that not only
NS1, but also the viral RNA polymerase subunits (PB2, PB1 and
PA) and the PB1-F2 proteins regulate IFN induction, possibly by
interactions with the mitochondrial MAVS/IPS receptor protein
for activated RIG-I [91–94]. It is therefore possible that (an)
uncharacterized polymorphism(s) in one or more of the respective
genes determines or contributes to the high- and low IFN
induction phenotypes of H5N1 strains. Even sequence compari-
sons of the two most potent IFN-b inducing strains Buzz/Bln and
Ch/Ind with the human H5N1 isolates did not reveal any known
polymorphic position(s) associated with a high virulence or IFN-b
inducing phenotype. Both avian strains differed from the human
H5N1 viruses in the HA1 (124, 212), PA (653), PB2 (339) and NA
(363, 435) proteins in addition to the previously discussed positions
in M1 and NS1. The differences in the HA proteins presumably
reflect that these viruses belong to different clades [95] and the
variations G363N and S435G in NA and Thr339Lys as in PB2 are
common to both avian and human H5N1 isolates [96]. Amino
acid 653 in the PA protein (S in both avian isolates instead of P in
the human H5N1 strains) is part of an a-helical region described to
be important for the interaction with PB1. The mutations E656A
und G657A are known to reduce this interaction resulting in
reduced transcription and replication of IAV [97,98]. To
determine if those or other individual differences in the
polymerase or other proteins encoded by human and avian
H5N1 isolates cause the different levels of IFN-a/b induction will
be part of future work. Future work may also clarify, whether the
human H5N1 isolates acquired their adaptation(s) during initial
replication in the human host [99], or if they were randomly
acquired in birds as a prerequisite for transmission into humans,
which would foster our ability to assess the zoonotic threat by
H5N1 strains [100].
Supporting Information
Figure S1 H5N1 virus replication in human Calu-3 and
normal human bronchial epithelial (NHBE) cells. Virus
growth on Calu-3 (A, MOI 0.01) and NHBE (B, MOI 1) cells was
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analyzed via plaque titration of samples of cell culture supernatants
taken at the indicated time points after infection (N$2,+SEM).
(TIF)
Figure S2 IFN-b secretion of influenza virus-infected
human monocyte derived macrophages. (A) Monocytic
cells were isolated from buffy coats of healthy human blood donors
and were differentiated in vitro. The resulting cultured cells are
shown to express the typical markers for macrophages via
antibody staining and FACS analysis. The prominent population
of cells in the forward/sideward scattering (.90% of the cells, data
not shown) expresses CD206, CD14, HLA-DR and little CD86.
Black lines indicate the number of cells with a specific signal
intensity of the used antibodies, grey lines represent isotype
antibody controls. (B) Monocyte-derived human macrophages
were infected for 24 h (MOI = 2) with the human and avian H5N1
strains, Pan/99 (H3N2) and its mutant variant with a deleted NS1
gene. IFN-b concentrations of cell culture supernatants were
determined via a bead-based cytokine assay (Panomics). Shown
are mean IFN-b concentrations +/2 SEM of macrophage
cultures obtained from three different donors independently
infected in triplicates.
(TIF)
Methods S1 Preparation and infection of monocyte-
derived macrophages and FACS analysis.
(DOCX)
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We thank Andrea Zöhner and Gudrun Heins for excellent technical
assistance, Brunhilde Schweiger for providing virus isolates, Marion Abt
and Vincent van Laak for advice to the macrophage preparation, Bastian
Opitz (Berlin, Germany) for siRNAs, Sven-Erik Behrens (Halle, Germany)
for helpful suggestions, and Aline Anton for comparing the growth of
natural and recombinant Pan/99 viruses.
Author Contributions
Conceived and designed the experiments: MM TW. Performed the
experiments: MM MB. Analyzed the data: MM MB TW. Wrote the paper:
MM MB TW.
References
1. Wright PF, Neumann G. (2007) Orthomyxoviruses. Fields Virology. 5 ed.
Philadelphia: Lippincott Williams & Wilkens. 1691–1740.
2. Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential
of swine-origin H1N1 influenza virus. Nature 459: 931–939.
3. Kawaoka Y, Krauss S, Webster RG (1989) Avian-to-human transmission of the
PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 63:
4603–4608.
4. Scholtissek C, Rohde W, Von Hoyningen V, Rott R (1978) On the origin of
the human influenza virus subtypes H2N2 and H3N2. Virology 87: 13–20.
5. Kalthoff D, Globig A, Beer M (2010) (Highly pathogenic) avian influenza as a
zoonotic agent. Vet Microbiol 140: 237–245.
6. Maines TR, Szretter KJ, Perrone L, Belser JA, Bright RA, et al. (2008)
Pathogenesis of emerging avian influenza viruses in mammals and the host
innate immune response. Immunol Rev 225: 68–84.
7. Connor RJ, Kawaoka Y, Webster RG, Paulson JC (1994) Receptor specificity
in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205:
17–23.
8. Gambaryan A, Tuzikov A, Pazynina G, Bovin N, Balish A, et al. (2006)
Evolution of the receptor binding phenotype of influenza A (H5) viruses.
Virology 344: 432–438.
9. Stevens J, Blixt O, Chen LM, Donis RO, Paulson JC, et al. (2008) Recent avian
H5N1 viruses exhibit increased propensity for acquiring human receptor
specificity. J Mol Biol 381: 1382–1394.
10. Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, et al. (2006)
Haemagglutinin mutations responsible for the binding of H5N1 influenza A
viruses to human-type receptors. Nature 444: 378–382.
11. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, et al. (2007)
Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract.
Nat Med 13: 147–149.
12. Oshansky CM, Pickens JA, Bradley KC, Jones LP, Saavedra-Ebner GM, et al.
(2011) Avian influenza viruses infect primary human bronchial epithelial cells
unconstrained by sialic acid alpha2,3 residues. PLoS One 6: e21183.
13. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, et al. (2006) Avian flu:
influenza virus receptors in the human airway. Nature 440: 435–436.
14. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, et al.
(2006) H5N1 Virus Attachment to Lower Respiratory Tract. Science 312: 399.
15. Weinheimer VK, Becher A, Tonnies M, Holland G, Knepper J, et al. (2012)
Influenza A Viruses Target Type II Pneumocytes in the Human Lung. J Infect
Dis.
16. Subbarao EK, London W, Murphy BR (1993) A single amino acid in the PB2
gene of influenza A virus is a determinant of host range. J Virol 67: 1761–1764.
17. Massin P, van der Werf S, Naffakh N (2001) Residue 627 of PB2 is a
determinant of cold sensitivity in RNA replication of avian influenza viruses.
J Virol 75: 5398–5404.
18. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, et
al. (2008) Update on avian influenza A (H5N1) virus infection in humans.
N Engl J Med 358: 261–273.
19. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal
outcome of human influenza A (H5N1) is associated with high viral load and
hypercytokinemia. Nat Med 12: 1203–1207.
20. Gao R, Dong L, Dong J, Wen L, Zhang Y, et al. (2010) A systematic molecular
pathology study of a laboratory confirmed H5N1 human case. PLoS One 5:
e13315.
21. Sirinonthanawech N, Uiprasertkul M, Suptawiwat O, Auewarakul P (2011)
Viral load of the highly pathogenic avian influenza H5N1 virus in infected
human tissues. J Med Virol 83: 1418–1423.
22. Uiprasertkul M, Kitphati R, Puthavathana P, Kriwong R, Kongchanagul A, et
al. (2007) Apoptosis and pathogenesis of avian influenza A (H5N1) virus in
humans. Emerg Infect Dis 13: 708–712.
23. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al. (2006) 59-
Triphosphate RNA is the ligand for RIG-I. Science 314: 994–997.
24. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al. (2006) RIG-I-
mediated antiviral responses to single-stranded RNA bearing 59-phosphates.
Science 314: 997–1001.
25. Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, et al. (2007) IFNbeta
induction by influenza A virus is mediated by RIG-I which is regulated by the
viral NS1 protein. Cell Microbiol 9: 930–938.
26. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, et al. (1998) Virus
infection induces the assembly of coordinately activated transcription factors on
the IFN-beta enhancer in vivo. Mol Cell 1: 507–518.
27. Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated
signalling. Nat Rev Immunol 5: 375–386.
28. Randall RE, Goodbourn S (2008) Interferons and viruses: an interplay between
induction, signalling, antiviral responses and virus countermeasures. J Gen
Virol 89: 1–47.
29. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, et al. (1998)
Influenza A virus lacking the NS1 gene replicates in interferon-deficient
systems. Virology 252: 324–330.
30. Guo Z, Chen LM, Zeng H, Gomez JA, Plowden J, et al. (2007) NS1 protein of
influenza A virus inhibits the function of intracytoplasmic pathogen sensor,
RIG-I. Am J Respir Cell Mol Biol 36: 263–269.
31. Ludwig S, Wang X, Ehrhardt C, Zheng H, Donelan N, et al. (2002) The
influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and
AP-1 transcription factors. J Virol 76: 11166–11171.
32. Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M Jr, et al.
(2007) Inhibition of retinoic acid-inducible gene I-mediated induction of beta
interferon by the NS1 protein of influenza A virus. J Virol 81: 514–524.
33. Talon J, Horvath CM, Polley R, Basler CF, Muster T, et al. (2000) Activation
of interferon regulatory factor 3 is inhibited by the influenza A virus NS1
protein. J Virol 74: 7989–7996.
34. Wang X, Li M, Zheng H, Muster T, Palese P, et al. (2000) Influenza A virus
NS1 protein prevents activation of NF-kappaB and induction of alpha/beta
interferon. J Virol 74: 11566–11573.
35. Wolff T, Zielecki F, Abt M, Voss D, Semmler I, et al. (2008) Sabotage of
antiviral signaling and effectors by influenza viruses. Biol Chem 389: 1299–
1305.
36. Chan MC, Cheung CY, Chui WH, Tsao SW, Nicholls JM, et al. (2005)
Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in
primary human alveolar and bronchial epithelial cells. Respir Res 6: 135.
37. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, et al. (2002) Induction of
proinflammatory cytokines in human macrophages by influenza A (H5N1)
viruses: a mechanism for the unusual severity of human disease? Lancet 360:
1831–1837.
38. Deng R, Lu M, Korteweg C, Gao Z, McNutt MA, et al. (2008) Distinctly
different expression of cytokines and chemokines in the lungs of two H5N1
avian influenza patients. J Pathol 216: 328–336.
IFN-b Induction by H5N1 Influenza A Virus
PLOS ONE | www.plosone.org 10 February 2013 | Volume 8 | Issue 2 | e56659
39. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, et al.
(1998) Human influenza A H5N1 virus related to a highly pathogenic avian
influenza virus. Lancet 351: 472–477.
40. Puthavathana P, Auewarakul P, Charoenying PC, Sangsiriwut K, Pooruk P, et
al. (2005) Molecular characterization of the complete genome of human
influenza H5N1 virus isolates from Thailand. J Gen Virol 86: 423–433.
41. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR (2001) Universal
primer set for the full-length amplification of all influenza A viruses. Arch Virol
146: 2275–2289.
42. Matrosovich M, Matrosovich T, Garten W, Klenk HD (2006) New low-
viscosity overlay medium for viral plaque assays. Virol J 3: 63.
43. Unterstab G, Ludwig S, Anton A, Planz O, Dauber B, et al. (2005) Viral
targeting of the interferon-{beta}-inducing Traf family member-associated NF-
{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A 102:
13640–13645.
44. Terrier O, Moules V, Carron C, Cartet G, Frobert E, et al. (2012) The
influenza fingerprints: NS1 and M1 proteins contribute to specific host cell
ultrastructure signatures upon infection by different influenza A viruses.
Virology 432: 204–218.
45. Kochs G, Koerner I, Thiel L, Kothlow S, Kaspers B, et al. (2007) Properties of
H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in
mice and chickens. J Gen Virol 88: 1403–1409.
46. Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, et al. (1988)
Homozygous deletion of the alpha- and beta 1-interferon genes in human
leukemia and derived cell lines. Proc Natl Acad Sci U S A 85: 5259–5263.
47. Desmyter J, Melnick JL, Rawls WE (1968) Defectiveness of interferon
production and of rubella virus interference in a line of African green monkey
kidney cells (Vero). J Virol 2: 955–961.
48. Wolff T, Ludwig S (2009) Influenza viruses control the vertebrate type I
interferon system: factors, mechanisms, and consequences. J Interferon
Cytokine Res 29: 549–557.
49. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. (2006)
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA
viruses. Nature 441: 101–105.
50. Jia D, Rahbar R, Chan RW, Lee SM, Chan MC, et al. (2010) Influenza virus
non-structural protein 1 (NS1) disrupts interferon signaling. PLoS One 5:
e13927.
51. Lycett SJ, Ward MJ, Lewis FI, Poon AF, Kosakovsky Pond SL, et al. (2009)
Detection of mammalian virulence determinants in highly pathogenic avian
influenza H5N1 viruses: multivariate analysis of published data. J Virol 83:
9901–9910.
52. Bussey KA, Bousse TL, Desmet EA, Kim B, Takimoto T (2010) PB2 residue
271 plays a key role in enhanced polymerase activity of influenza A viruses in
mammalian host cells. J Virol 84: 4395–4406.
53. Conenello GM, Tisoncik JR, Rosenzweig E, Varga ZT, Palese P, et al. (2011)
A single N66S mutation in the PB1-F2 protein of influenza A virus increases
virulence by inhibiting the early interferon response in vivo. J Virol 85: 652–
662.
54. Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P (2007) A single
mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses
contributes to increased virulence. PLoS Pathog 3: 1414–1421.
55. Long JX, Peng DX, Liu YL, Wu YT, Liu XF (2008) Virulence of H5N1 avian
influenza virus enhanced by a 15-nucleotide deletion in the viral nonstructural
gene. Virus Genes 36: 471–478.
56. Twu KY, Kuo RL, Marklund J, Krug RM (2007) The H5N1 influenza virus
NS genes selected after 1998 enhance virus replication in mammalian cells.
J Virol 81: 8112–8121.
57. Min JY, Li S, Sen GC, Krug RM (2007) A site on the influenza A virus NS1
protein mediates both inhibition of PKR activation and temporal regulation of
viral RNA synthesis. Virology 363: 236–243.
58. WHO (2012) In:Organisation WH, editor.
59. Govorkova EA, Rehg JE, Krauss S, Yen HL, Guan Y, et al. (2005) Lethality to
ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.
J Virol 79: 2191–2198.
60. Le QM, Ito M, Muramoto Y, Hoang PV, Vuong CD, et al. (2010)
Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated
from humans between 2003 and 2008 in northern Vietnam. J Gen Virol 91:
2485–2490.
61. Wang TT, Parides MK, Palese P (2012) Seroevidence for H5N1 influenza
infections in humans: meta-analysis. Science 335: 1463.
62. Didcock L, Young DF, Goodbourn S, Randall RE (1999) Sendai virus and
simian virus 5 block activation of interferon-responsive genes: importance for
virus pathogenesis. J Virol 73: 3125–3133.
63. Lee MH, Lalwani P, Raftery MJ, Matthaei M, Lutteke N, et al. (2011) RNA
helicase retinoic acid-inducible gene I (RIG-I) as a sensor of Hantaan virus
(HTNV) replication. J Gen Virol.
64. McFadden G, Mohamed MR, Rahman MM, Bartee E (2009) Cytokine
determinants of viral tropism. Nat Rev Immunol 9: 645–655.
65. Valmas C, Basler CF (2011) Marburg virus VP40 antagonizes interferon
signaling in a species-specific manner. J Virol 85: 4309–4317.
66. Wang F, Ma Y, Barrett JW, Gao X, Loh J, et al. (2004) Disruption of Erk-
dependent type I interferon induction breaks the myxoma virus species barrier.
Nat Immunol 5: 1266–1274.
67. Kugel D, Kochs G, Obojes K, Roth J, Kobinger GP, et al. (2009) Intranasal
administration of alpha interferon reduces seasonal influenza A virus morbidity
in ferrets. J Virol 83: 3843–3851.
68. Szretter KJ, Gangappa S, Belser JA, Zeng H, Chen H, et al. (2009) Early
control of H5N1 influenza virus replication by the type I interferon response in
mice. J Virol 83: 5825–5834.
69. Van Hoeven N, Belser JA, Szretter KJ, Zeng H, Staeheli P, et al. (2009)
Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a
guinea pig model: antiviral potential of exogenous alpha interferon to reduce
virus shedding. J Virol 83: 2851–2861.
70. Haasbach E, Droebner K, Vogel AB, Planz O (2011) Low-dose interferon
Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A
viruses in vitro and in vivo. J Interferon Cytokine Res 31: 515–525.
71. Hayman A, Comely S, Lackenby A, Hartgroves LC, Goodbourn S, et al.
(2007) NS1 proteins of avian influenza A viruses can act as antagonists of the
human alpha/beta interferon response. J Virol 81: 2318–2327.
72. Ocana-Macchi M, Bel M, Guzylack-Piriou L, Ruggli N, Liniger M, et al.
(2009) Hemagglutinin-dependent tropism of H5N1 avian influenza virus for
human endothelial cells. J Virol 83: 12947–12955.
73. Geiler J, Michaelis M, Sithisarn P, Cinatl J Jr (2011) Comparison of pro-
inflammatory cytokine expression and cellular signal transduction in human
macrophages infected with different influenza A viruses. Med Microbiol
Immunol 200: 53–60.
74. Hayman A, Comely S, Lackenby A, Murphy S, McCauley J, et al. (2006)
Variation in the ability of human influenza A viruses to induce and inhibit the
IFN-beta pathway. Virology 347: 52–64.
75. Brennan K, Bowie AG (2010) Activation of host pattern recognition receptors
by viruses. Curr Opin Microbiol 13: 503–507.
76. Zhang Z, Kim T, Bao M, Facchinetti V, Jung SY, et al. (2011) DDX1,
DDX21, and DHX36 helicases form a complex with the adaptor molecule
TRIF to sense dsRNA in dendritic cells. Immunity 34: 866–878.
77. Hui KP, Lee SM, Cheung CY, Mao H, Lai AK, et al. (2011) H5N1 influenza
virus-induced mediators upregulate RIG-I in uninfected cells by paracrine
effects contributing to amplified cytokine cascades. J Infect Dis 204: 1866–
1878.
78. Forbes NE, Ping J, Dankar SK, Jia JJ, Selman M, et al. (2012) Multifunctional
adaptive NS1 mutations are selected upon human influenza virus evolution in
the mouse. PLoS One 7: e31839.
79. Hatta M, Gao P, Halfmann P, Kawaoka Y (2001) Molecular basis for high
virulence of Hong Kong H5N1 influenza A viruses. Science 293: 1840–1842.
80. Jiao P, Tian G, Li Y, Deng G, Jiang Y, et al. (2008) A single-amino-acid
substitution in the NS1 protein changes the pathogenicity of H5N1 avian
influenza viruses in mice. J Virol 82: 1146–1154.
81. Imai H, Shinya K, Takano R, Kiso M, Muramoto Y, et al. (2010) The HA and
NS genes of human H5N1 influenza A virus contribute to high virulence in
ferrets. PLoS Pathog 6: e1001106.
82. Dankar SK, Wang S, Ping J, Forbes NE, Keleta L, et al. (2011) Influenza A
virus NS1 gene mutations F103L and M106I increase replication and
virulence. Virol J 8: 13.
83. Baum A, Sachidanandam R, Garcia-Sastre A (2010) Preference of RIG-I for
short viral RNA molecules in infected cells revealed by next-generation
sequencing. Proc Natl Acad Sci U S A 107: 16303–16308.
84. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, et al. (2010) RIG-I
detects viral genomic RNA during negative-strand RNA virus infection. Cell
140: 397–408.
85. Wang Q, Zhang S, Jiang H, Wang J, Weng L, et al. (2012) PA from an H5N1
highly pathogenic avian influenza virus activates viral transcription and
replication and induces apoptosis and interferon expression at an early stage of
infection. Virol J 9: 106.
86. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, et al. (2005) The viral
polymerase mediates adaptation of an avian influenza virus to a mammalian
host. Proc Natl Acad Sci U S A 102: 18590–18595.
87. Mehle A, Doudna JA (2008) An inhibitory activity in human cells restricts the
function of an avian-like influenza virus polymerase. Cell Host Microbe 4: 111–
122.
88. Bortz E, Westera L, Maamary J, Steel J, Albrecht RA, et al. (2011) Host- and
strain-specific regulation of influenza virus polymerase activity by interacting
cellular proteins. MBio 2.
89. Robb NC, Smith M, Vreede FT, Fodor E (2009) NS2/NEP protein regulates
transcription and replication of the influenza virus RNA genome. J Gen Virol
90: 1398–1407.
90. Manz B, Brunotte L, Reuther P, Schwemmle M (2012) Adaptive mutations in
NEP compensate for defective H5N1 RNA replication in cultured human cells.
Nat Commun 3: 802.
91. Dudek SE, Wixler L, Nordhoff C, Nordmann A, Anhlan D, et al. (2011) The
influenza virus PB1-F2 protein has interferon-antagonistic activity. Biol Chem.
92. Graef KM, Vreede FT, Lau YF, McCall AW, Carr SM, et al. (2010) The PB2
subunit of the influenza virus RNA polymerase affects virulence by interacting
with the mitochondrial antiviral signaling protein and inhibiting expression of
beta interferon. J Virol 84: 8433–8445.
93. Iwai A, Shiozaki T, Kawai T, Akira S, Kawaoka Y, et al. (2010) Influenza A
virus polymerase inhibits type I interferon induction by binding to interferon
beta promoter stimulator 1. J Biol Chem 285: 32064–32074.
IFN-b Induction by H5N1 Influenza A Virus
PLOS ONE | www.plosone.org 11 February 2013 | Volume 8 | Issue 2 | e56659
94. Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, et al. (2011) The
influenza virus protein PB1-F2 inhibits the induction of type i interferon at the
level of the MAVS adaptor protein. PLoS Pathog 7: e1002067.
95. Wu WL, Chen Y, Wang P, Song W, Lau SY, et al. (2008) Antigenic profile of
avian H5N1 viruses in Asia from 2002 to 2007. J Virol 82: 1798–1807.
96. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, et al. (2008) The
influenza virus resource at the National Center for Biotechnology Information.
J Virol 82: 596–601.
97. He X, Zhou J, Bartlam M, Zhang R, Ma J, et al. (2008) Crystal structure of the
polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus.
Nature 454: 1123–1126.
98. Regan JF, Liang Y, Parslow TG (2006) Defective assembly of influenza A virus
due to a mutation in the polymerase subunit PA. J Virol 80: 252–261.
99. Le QM, Sakai-Tagawa Y, Ozawa M, Ito M, Kawaoka Y (2009) Selection of
H5N1 influenza virus PB2 during replication in humans. J Virol 83: 5278–
5281.
100. Pepin KM, Lass S, Pulliam JR, Read AF, Lloyd-Smith JO (2010) Identifying
genetic markers of adaptation for surveillance of viral host jumps. Nat Rev
Microbiol 8: 802–813.
101. Fukuyama S, Kawaoka Y (2011) The pathogenesis of influenza virus infections:
the contributions of virus and host factors. Curr Opin Immunol 23: 481–486.
IFN-b Induction by H5N1 Influenza A Virus
PLOS ONE | www.plosone.org 12 February 2013 | Volume 8 | Issue 2 | e56659
